The Department of Health and Human Services has ended a contract with a firm over its use of fetal tissue for medical research purposes.

The $15,900 contract between the FDA and Advanced Bioscience Resources, Inc. was signed in July and involved the company acquiring tissue from aborted fetuses.

“Fresh human tissues are required for implantation into severely immune-compromised mice to create chimeric animals that have a human immune system,” the notice about the contract read, according to CNS News.

HHS issued a press release Monday that said the contract was torn up.

Read more

Democrats’ Goal In November Is To Win Congress So They Can Impeach President Trump

Related Articles